Delivery Order SPE2DB22D2006-SPE2DB26FV5WB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits valued at $10,499.78. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for ultimate completion by June 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Lupron Depot 22.5 mg 3-month kits, with a ceiling value of $2,222.07 and an ultimate completion date of October 21, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 9, 2025, for Lupron Depot 11.25 mg 3-month kits valued at $22,374.10 under a firm fixed-price contract with an ultimate completion date of May 12, 2025. This non-set-aside award represents a competitively awarded delivery order for pharmaceutical supplies to support military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $17,759.51 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded with a completion date of September 9, 2025. The award was made to AmerisourceBergen's corporate office, with performance to be executed at the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits valued at $46,242.51 under a firm fixed-price contract type. The order was competitively awarded with no set-aside designation and is scheduled for completion by September 22, 2025. AmerisourceBergen will perform the delivery from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,712.23 to AmerisourceBergen Drug Corp on September 19, 2025, for Lupron Depot 11.25 mg 3-month kits, with an ultimate completion date of September 22, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award to the vendor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lupron Depot 45 mg 6-month kits valued at $3,086.97 under a firm fixed price contract. The award was issued on October 21, 2025, with an ultimate completion date of October 22, 2025, and represents a non-set-aside competitive procurement. The product will be performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month treatment kits under a firm fixed-price contract. The award, valued at $47,687.90 and dated April 23, 2025, represents a single delivery order with an ultimate completion date of April 24, 2025. This contract was competitively awarded with no set-aside designation, and performance will be executed from the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,371.84 to AmerisourceBergen Drug Corp for Lupron Depot 22.5 mg 3-month kits, with an ultimate completion date of August 13, 2025. This non-competitive delivery order represents a firm fixed price transaction under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, valued at $3,344.81. This delivery order is issued under a firm fixed-price contract type with no set-aside designation, indicating competitive award. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 8, 2025. This delivery order represents a...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB26FV5WBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 26, 2025, for the supply of Lupron Depot 22.5 mg 3-month kits at a ceiling value of $2,743.68. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is expected to be completed by October 27, 2025. The delivery order is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide. AmerisourceBergen's demonstrated capability to fulfill competitive federal medical procurement requirements, combined with its extensive pharmaceutical portfolio spanning specialty medications, brand-name and generic drugs, and medical devices, positions the company as a critical vendor supporting Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 10/26/25 |